Myeloma New Zealand Calls on Pharmac to Make Good on Access Deal
Press Release: Medianet Myeloma New Zealand is today calling on Pharmac to make good on their proposal to widen access to blood cancer treatment lenalidomide (Revlimid) from April this year, allowing eligible patients access the subsidised drug earlier in their course of treatment. As one of several groups that marched